Skip to Content

Join the 'Myasthenia Gravis' group to help and get support from people like you.

Myasthenia Gravis News

FDA Approves Soliris (eculizumab) for the Treatment of Patients with Generalized Myasthenia Gravis (GMG)

Posted 26 Oct 2017 by Drugs.com

NEW HAVEN, Conn.--(BUSINESS WIRE) October 23, 2017 --Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) announced today that the U.S. Food and Drug Administration (FDA) has approved Soliris (eculizumab) as a treatment for adult patients with generalized myasthenia gravis (gMG) who are anti-acetylcholine receptor (AchR) antibody-positive. In the Phase 3 REGAIN study and its ongoing open-label extension study, Soliris demonstrated treatment benefits for patients with anti-AchR antibody-positive gMG who had previously failed immunosuppressive treatment and continued to suffer from significant unresolved disease symptoms, which can include difficulties seeing, walking, talking, swallowing and breathing. These patients are at an increased risk of disease exacerbations and crises that may require hospitalization and intensive care and may be life-threatening. These patients represent approximately ... Read more

Related support groups: Myasthenia Gravis, Soliris, Eculizumab

Surgery Effective Against Immune Disorder That Weakens Muscles

Posted 11 Aug 2016 by Drugs.com

THURSDAY, Aug. 11, 2016 – Removing the thymus gland is an effective treatment for myasthenia gravis, an autoimmune disorder that causes life-threatening muscle weakness, researchers report. Since the 1940s, doctors have been surgically removing the thymus gland – a procedure called thymectomy – as a means of treating myasthenia gravis. But this has been done based on research indicating the gland might play a role in the development of the disease. "It has never been clearly shown to benefit patients beyond other medical therapies that have developed over time," said lead researcher Dr. Gil Wolfe. He's the chair of neurology for the Jacobs School of Medicine and Biomedical Sciences at the University at Buffalo in New York. "There has always been a question of how much favorable impact it actually provides," Wolfe said. Now, Wolfe and his colleagues have proven that thymectomy offers ... Read more

Related support groups: Surgery, Myasthenia Gravis, Head & Neck Surgery

FDA Bolsters Warnings About Class of Antibiotics

Posted 26 Jul 2016 by Drugs.com

TUESDAY, July 26, 2016 – The U.S. Food and Drug Administration announced Tuesday that it's strengthening label warnings on a class of antibiotics called fluoroquinolones because the drugs can lead to disabling side effects, including long-term nerve damage and ruptured tendons. The agency also cautioned that these bacteria-fighting drugs – including levofloxacin (Levaquin) and ciprofloxacin (Cipro) – shouldn't be prescribed for sinusitis, chronic bronchitis or simple urinary tract infections unless no other treatments options exist. "Fluoroquinolones have risks and benefits that should be considered very carefully," Dr. Edward Cox said in an FDA news release. He's director of the Office of Antimicrobial Products at the FDA's Center for Drug Evaluation and Research. "It's important that both health care providers and patients are aware of both the risks and benefits of ... Read more

Related support groups: Infections, Urinary Tract Infection, Peripheral Neuropathy, Sinusitis, Bladder Infection, Cipro, Bronchitis, Ciprofloxacin, Levaquin, Levofloxacin, Kidney Infections, Myasthenia Gravis, Avelox, Ofloxacin, Vigamox, Ciprodex, Sinus Symptoms, Moxifloxacin, Norfloxacin, Gatifloxacin

Ask a Question

Further Information

Related Condition Support Groups

Neurologic Disorder

Related Drug Support Groups

azathioprine, Mestinon, ephedrine, pyridostigmine, mycophenolate mofetil, huperzine a, immune globulin intravenous, neostigmine, Soliris, view more... Regonol, Mestinon Timespan, Prostigmin Bromide, ambenonium, Prostigmin, Mytelase, eculizumab, Mytelase Chloride